Effects of phytochemicals sulforaphane on uridine diphosphate-glucuronosyltransferase expression as well as cell-cycle arrest and apoptosis in human colon cancer Caco-2 cells

Chin J Physiol. 2012 Apr 30;55(2):134-44. doi: 10.4077/CJP.2012.BAA085.

Abstract

Our study investigated the effects of the chemopreventive agent sulforaphane (SFN) on human colon cancer Caco-2 cells and potential underlying mechanisms of the effects. When treated with SFN at hypotoxic levels, UDP-glucuronosyltransferase 1A (UGT1A) was induced in a dose-dependent manner. SFN at 25 μM showed the highest UGT1A-induction activity, inducing UGT1A1, UGT1A8, and UGT1A10 mRNA expression, and increasing UGT-mediated N-hydroxy-PhIP glucuronidation. SFN- induced UGT1A expression may have resulted from Nrf2 nuclear translocation or activation. At higher concentrations, e.g. 75 μM, SFN caused G1/G2 cell cycle arrest and induced apoptosis possibly through reducing anti-apoptotic bcl-2 expression and increasing apoptosis-inducing bax expression in Caco-2 cells. Taken together, these results demonstrated the chemopreventive effects of SFN on human colon cancer Caco-2 cells may have been partly attributed to Nrf2-mediated UGT1A induction and apoptosis induction, and our studies provided theoretic and experimental basis for clinical application of SFN to human colon cancer prevention.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / drug effects*
  • Apoptosis / physiology
  • Caco-2 Cells
  • Cell Cycle Checkpoints / drug effects*
  • Cell Cycle Checkpoints / physiology
  • Cell Nucleus / metabolism
  • Colonic Neoplasms* / drug therapy
  • Colonic Neoplasms* / enzymology
  • Colonic Neoplasms* / pathology
  • G1 Phase / drug effects
  • G1 Phase / physiology
  • Gene Expression Regulation, Enzymologic / drug effects
  • Glucuronates / metabolism
  • Glucuronosyltransferase / genetics*
  • Glucuronosyltransferase / metabolism
  • Humans
  • Isothiocyanates
  • NF-E2-Related Factor 2 / metabolism
  • Proto-Oncogene Proteins c-bcl-2 / genetics
  • Proto-Oncogene Proteins c-bcl-2 / metabolism
  • Resting Phase, Cell Cycle / drug effects
  • Resting Phase, Cell Cycle / physiology
  • Sulfoxides
  • Thiocyanates / pharmacology*
  • bcl-2-Associated X Protein / genetics
  • bcl-2-Associated X Protein / metabolism

Substances

  • BAX protein, human
  • Glucuronates
  • Isothiocyanates
  • NF-E2-Related Factor 2
  • NFE2L2 protein, human
  • Proto-Oncogene Proteins c-bcl-2
  • Sulfoxides
  • Thiocyanates
  • bcl-2-Associated X Protein
  • UGT1A1 enzyme
  • bilirubin uridine-diphosphoglucuronosyl transferase 1A10
  • Glucuronosyltransferase
  • UDP-glucuronosyltransferase, UGT1A8
  • sulforaphane